The Mesothelioma Applied Research
THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION, INC. MISSION IS TO OFFER HOPE AND SUPPORT TO PATIENTS AND FAMILIES DEALING WITH MESOTHELIOMA. THIS IS ACCOMPLISHED BY EDUCATING PATIENTS AND FAMILIES ABOUT THE DISEASE, HELPING THEM OBTAIN THE MOST UP-TO-DATE INFORMATION ON TREATMENT OPTIONS, CONNECTING THEM WITH MESOTHELIOMA TREATMENT SPECIALISTS, AND PROVIDING ASSISTANCE, EMOTIONAL SUPPORT, AND COMMUNITY WITH OTHERS. THE FOUNDATION PROVIDES FUNDING TO THE HIGHEST QUALITY AND MOST PROMISING MESOTHELIOMA RESEARCH PROJECTS WORLDWIDE THROUGH RIGOROUS PEER-REVIEW. THE FOUNDATION ALSO WORKS TO RAISE AWARENESS OF THE DISEASE, AND ADVOCATES THAT THE PUBLIC AND PRIVATE SECTORS PARTNER IN THE EFFORT TO CURE IT BY DIRECTING THE RESOURCES NEEDED TO STOP THIS GLOBAL TRAGEDY.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$10.6M
+6.7% YoY
Annual Giving
$200K
Grant Count
2
Avg Grant Size
$100K
About The Mesothelioma Applied Research
Based on IRS filings
The Mesothelioma Applied Research is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in WASHINGTON, DC. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $10.6M in total assets. In 2024, it awarded 2 grants totaling $200K. Net investment income was $679K.
Focus Areas
Ready to take the next step with The Mesothelioma Applied Research?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $10,638,848 | $9,971,454 | $9,449,879 |
| Revenue | $2,018,146 | $1,546,869 | $1,693,216 |
| Expenses | $1,403,070 | $1,532,223 | $1,190,526 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $679,349 | $122,229 | $-221,948 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 2 recipients in 2024
Grant Size Distribution
5 grants across all recorded years
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest include Brigham and Women's Hospital ($100,000), The University of Chicago ($100,000).
| Recipient | Purpose | Amount |
|---|---|---|
| BRIGHAM AND WOMEN'S HOSPITAL BOSTON, MA | RESEARCH GRANT | $100,000 |
| THE UNIVERSITY OF CHICAGO CHICAGO, IL | RESEARCH GRANT | $100,000 |
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| MARJORIE G ZAUDERER MD MS FACP | CHAIR | 1 | — |
| DARCIENA ANDERSON CHRISTEL | TREASURER | 1 | — |
| R TAYLOR RIPLEY MD | VICE CHAIR | 1 | — |
| KEITH CENGEL MD PHD | SECRETARY | 1 | — |
| JASON M FOSTER MD | DIRECTOR | 1 | — |
| AARON S MANSFIELD MD | DIRECTOR (STEPPED DOWN IN 2024) | 1 | — |
| SANJAY POPAT PHD | DIRECTOR (STEPPED DOWN IN 2024) | 1 | — |
| BORIS SEPESI MD | DIRECTOR (MEMBERSHIP PAUSED IN 2024) | 1 | — |
| DANIEL STERMAN MD | DIRECTOR | 1 | — |
| JAMES STEVENSON MD | DIRECTOR | 1 | — |
| WILLIAM N ZIEGLER | DIRECTOR | 1 | — |
| CHERYL BRUNER ESQ | DIRECTOR | 1 | — |
| JESSICA BLACKFORD-CLEETON | DIRECTOR | 1 | — |
| BRIAN T LEPACEK | EXECUTIVE DIRECTOR | 40 | $53,910 |
| JULIE WHITE | HIGHEST COMPENSATED EMPLOYEE | 40 | $127,500 |
Subject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What is The Mesothelioma Applied Research?
The Mesothelioma Applied Research is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in WASHINGTON, DC. It holds $10.6M in total assets as of 2024.
How large is The Mesothelioma Applied Research?
As of 2024, The Mesothelioma Applied Research holds $10.6M in total assets with $2.0M in annual revenue. It awarded 2 grants totaling $200K in 2024.
Where does The Mesothelioma Applied Research operate?
The Mesothelioma Applied Research has awarded grants in District of Columbia, Illinois, Massachusetts, Maryland, North Carolina.
What size grants does The Mesothelioma Applied Research award?
In 2024, The Mesothelioma Applied Research awarded 2 grants totaling $200K — an average of about $100K per grant, based on its IRS Form 990 filings.
What is The Mesothelioma Applied Research's EIN?
The Mesothelioma Applied Research's EIN (Employer Identification Number) is 75-2816066. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in The Mesothelioma Applied Research's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Northwestern University
EVANSTON, IL
Assets
$19.2B
Grants
375
Total Given
$122.4M
The Susan G Komen Breast Cancer Foundation Inc
DALLAS, TX
Assets
$178.9M
Grants
61
Total Given
$16.1M
Amyotrophic Lateral Sclerosis Assn
ARLINGTON, VA
Assets
$107.2M
Grants
143
Total Given
$8.4M
The Commonwealth Fund
NEW YORK, NY
Assets
$922.7M
Grants
534
Total Given
$31.3M
Alzheimer's Disease & Related Disorders
CHICAGO, IL
Assets
$523.7M
Grants
79
Total Given
$73.3M
Jewish Community Federation of San
SAN FRANCISCO, CA
Assets
$1.5B
Grants
991
Total Given
$123.7M
Yale University
NEW HAVEN, CT
Assets
$55.2B
Grants
344
Total Given
$137.2M
Johns Hopkins University
BALTIMORE, MD
Assets
$23.0B
Grants
757
Total Given
$467.3M
Seattle Children's Hospital
SEATTLE, WA
Assets
$5.6B
Grants
171
Total Given
$43.0M
The Robert Wood Johnson Foundation
PRINCETON, NJ
Assets
$13.4B
Grants
3,093
Total Given
$622.6M
The Winston-Salem Foundation
WINSTONSALEM, NC
Assets
$630.1M
Grants
823
Total Given
$88.8M
Alliance Nctn Foundation
CHICAGO, IL
Assets
$4.5M
Grants
70
Total Given
$3.6M
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with The Mesothelioma Applied Research on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities
Go from researching The Mesothelioma Applied Research to a real strategy.